Our December issue is now online: www.thelancet.com/journals/lan... Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #Bordetela #pertussis #scabies #Neisseria #Chlamydia #HIV #TB #AMR #phage #Mycoplasma #Ebola #IDSky #ClinMicro #OA

New Podcast Apple - podcasts.apple.com/us/podcast/j... Spotify - open.spotify.com/episode/5EjT... Buzzsprout - www.buzzsprout.com/admin/174031...

📢 December issue now online featuring #asthma, #pneumonia, #sepsis, #epilepsy, #HIV, #PCOS, #depression, #UTI, and much more with our editorial on the future of prostate cancer screening …all available #free #OpenAccess❗️ Read more here: www.thelancet.com/issue/S2589-... Attribution: Getty #MedSky

Read our January issue! Featuring Sotrovimab in hospitalised COVID-19 patients, global policy responses to antimicrobial resistance, and evaluating dengue vaccination in Brazilian adolescents www.thelancet.com/issue/S1473-...

New Research Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study www.thelancet.com/journals/lan...

New Research Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 www.thelancet.com/journals/lan...

New research: Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study www.thelancet.com/journals/lan...

New research: Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study www.thelancet.com/journals/lan...

New personal view: Transitioning to people-centred antimicrobial resistance surveillance www.thelancet.com/journals/lan...

New research: Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil www.thelancet.com/journals/lan...

New research article Prospective characterisation of drug-resistant bloodstream infections in Africa and Asia (ACORN2): a surveillance network assessment www.thelancet.com/journals/lan... #IDSky #ClinMicro #AMR #OpenAccess #OA

Our December issue is now live! www.thelancet.com/journals/lan... Featuring: 👉🏻 The global burden of sepsis www.thelancet.com/journals/lan... 👉🏻 Violence against women in informal settlements www.thelancet.com/journals/lan... 👉🏻 Equitable RSV prevention in infants www.thelancet.com/journals/lan...

The Global Fund has fallen short of its $18 billion target, risking the progress made against AIDS, TB, and malaria. Our latest Editorial discusses the challenges and opportunities in shaping the future of global health investment. Read this & more: spkl.io/63321A5zXh

New Review Best practice guidelines for viral hepatitis service delivery in prisons www.thelancet.com/journals/lan...

New Research Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial www.thelancet.com/journals/lan...

New Research Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis www.thelancet.com/journals/lan...

New research article #HIV drug resistance during #antiretroviral therapy scale-up in Uganda, 2012–19: a population-based, longitudinal study www.thelancet.com/journals/lan... #IDSky #ClinMicro #ViroSky #AMR #OpenAccess #OA

New Research The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling study www.thelancet.com/journals/lan...

New Review: Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia www.thelancet.com/journals/lan...

New comment: Strengthening global preparedness and response to arboviral disease threats: a call to action www.thelancet.com/journals/lan...

New Research: Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study www.thelancet.com/journals/lan...

New comment: The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action www.thelancet.com/journals/lan...

Read our December issue! Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica. www.thelancet.com/issue/S1473-...

New Research Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study www.thelancet.com/journals/lan...

New Research: National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study www.thelancet.com/journals/lan...

The role of AI in infectious diseases is emerging—offering new opportunities for infection prevention, detection & control. Explore developments & practical applications ⤵️ spkl.io/63323Ad83c @thelancetinfdis.bsky.social #WorldAMRAwarenessWeek

New Research Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis www.thelancet.com/journals/lan...

New Research Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study www.thelancet.com/journals/lan...

New Research Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial www.thelancet.com/journals/lan...

@seanong.bsky.social takes to the next level analysis of the BALANCE trial (7 vs 14 days of antibiotics) and impact of protocol non-adherence (there was about 20% non-adherence to protocol durations). Read his thread and read his paper! @thelancetinfdis.bsky.social @thedohertyinst.bsky.social

New Research Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial www.thelancet.com/journals/lan...

New Personal View Post-tuberculosis lung disease: a case definition for use in research studies www.thelancet.com/journals/lan...

New Review British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update www.thelancet.com/journals/lan...

Our November issue is now online: www.thelancet.com/journals/lan... Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza #IDSky #ClinMicro #OA

New Comment Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease www.thelancet.com/journals/lan...

New Research Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study www.thelancet.com/journals/lan...

New Research Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trial www.thelancet.com/journals/lan...

New Research Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 www.thelancet.com/journals/lan...

New Review: Kyasanur Forest disease: an emerging arboviral threat www.thelancet.com/journals/lan...

New Comment G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults www.thelancet.com/journals/lan...

The November issue is now live! www.thelancet.com/journals/lan... Post-partum haemorrhage www.thelancet.com/journals/lan... Impact of breastfeeding on the global burden of NCDs in mothers and children www.thelancet.com/journals/lan... Vaccine ecosystem in Africa www.thelancet.com/journals/lan...

📅 Marco De Ambrogi will be attending ASTMH 2025, #TropMed25, November 9-13, 2025 in Toronto, Ontario, Canada on behalf of The Lancet Infectious Diseases! 📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0

Derivation and external validation of community-acquired #pneumonia subphenotypes in Southeast Asia: a secondary analysis of prospective cohort studies These subphenotypes may represent unique targets for future #CAP interventional trials www.thelancet.com/journals/ecl... #MedSky

New Research Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial www.thelancet.com/journals/lan...

New Research Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study www.thelancet.com/journals/lan...

New comment: Tuberculosis and undernutrition: improving estimates to reinforce the policy imperative www.thelancet.com/journals/lan...

Community-acquired pneumonia is the leading infectious cause of morbidity and mortality globally. Yet, there are several challenges associated with diagnosis, treatment, and long-term management of Community-acquired pneumonia. Find out more in a new Seminar: tinyurl.com/hd2fwz7n

New Personal View Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development www.thelancet.com/journals/lan...

New podcast @steventong.bsky.social Buzzsprout - www.buzzsprout.com/1740310/epis... Apple - podcasts.apple.com/gb/podcast/i... Spotify - open.spotify.com/episode/588l...

Read our November issue! Featuring testing olorofim to treat fungal infections, introduction of nirsevimab for RSV in Chile, and new oxazolidinones for tuberculosis therapy. www.thelancet.com/issue/S1473-...